|
S.No. |
Product Name |
Product Description |
|
1 |
MEFLUVAC™ H9 0.3 |
Monovalent vaccine against LPAI subtype H9N2 G1-lineage, in concentrated form |
|
2 |
MEFLUVAC™ H9-16 |
Monovalent vaccine against LPAI subtype H9N2 G1-lineage |
|
3 |
MEFLUVAC™ H9-16 0.3 |
Monovalent vaccine against Low Pathogenic Avian Influenza H9N2 belonging to G1-lineage, in concentrated form
|
|
4 |
MEFLUVAC™ H9 ND-16 |
Bivalent vaccine against LPAI subtype H9N2 and Newcastle Disease GII virus LaSota strain |
|
5 |
MEFLUVAC™ H9+ND7 0.3 |
Bivalent vaccine against LPAI subtype H9N2 and Newcastle Disease GVII virus, in concentrated form |
|
6 |
MEFLUVAC™ H9+ND7 |
Trivalent vaccine against LPAI (subtype H9N2) and Newcastle Disease (GII LaSota strain and GVII virus) |
|
7 |
MEFLUVAC™ H9+ND IMMUBOOST |
Trivalent vaccine against LPAI (subtype H9N2) and Newcastle Disease (GII LaSota strain and GVII virus) |
|
8 |
MEFLUVAC™ H5 PLUS 8 |
Trivalent vaccine against HPAI subtypes H5N1 (2.2.1.1 and 2.2.1.2) and H5N8 (2.3.4.4b) |
|
9 |
MEFLUVAC™ H5+ND7 |
Pentavalent vaccine against HPAI subtypes H5N1 (2.2.1.1 and 2.2.1.2), H5N8 (2.3.4.4b), NDV GII LaSota strain and NDV GVII virus |
|
10 |
MEFLUVAC™ H5+H9+ND7 |
Hexavalent vaccine against HPAI subtypes H5N1 (clades 2.2.1.1 and 2.2.1.2), and H5N8 (clade 2.3.4.4b), LPAI subtype H9N2 G1-lineage, NDV GII LaSota strain and NDV GVII virus |
|
11 |
MEFLUVAC™ H5+H9 |
Tetravalent vaccine against HPAI subtypes H5N1 (2.2.1.1 and 2.2.1.2), and H5N8 (2.3.4.4b) and LPAI subtype H9N2 G1- lineage |
|
12 |
MEVAC™ ND LASOTA |
Monovalent freeze-dried live attenuated Newcastle Disease virus LaSota strain (ME/NDV3) |
|
13 |
MEVAC™ ND ELITE |
Monovalent freeze-dried live attenuated Newcastle Disease virus (NDV GII) VG/GA strain |
|
14 |
MEVAC™ ND HB1 |
Monovalent freeze-dried live attenuated Newcastle Disease virus GII Hitchner B1 (ME/NDV1) |
|
15 |
RINNOVAC™ ELI-7 |
Monovalent recombinant freeze-dried live virus vaccine containing NDV GII VG/GA strain and NDV GVII virus |
|
16 |
MEVAC™ ND |
Monovalent Newcastle Disease virus GII vaccine LaSota strain |
|
17 |
MEVAC™ ND BROILER |
Monovalent NDV virus GII LaSota strain vaccine, in concentrated form |
|
18 |
MEVAC™ ND7 PLUS |
Bivalent recombinant NDV GVII virus and NDV GII LaSota strain |
|
19 |
MEVAC™ ND7 PLUS BROILER |
Bivalent recombinant NDV GVII virus (ME.G7/2017) and GII LaSota strain, in concentrated form |
|
20 |
MEVAC™ IB H120 |
Monovalent freeze-dried live attenuated Infectious Bronchitis Disease Virus Vaccine (Classic H120) |
|
21 |
MEVAC™ IB VAR 2 |
Monovalent freeze-dried live attenuated Infectious Bronchitis virus GI-23 lineage strain (VAR 2) |
|
22 |
MEVAC™ MULTI IB |
Trivalent vaccine against Infectious Bronchitis (Classic M41, GI-13 and GI-23 lineage strains) virus |
|
23 |
MEVAC™ MULTI IB+H9 |
Tetravalent vaccine against Infectious Bronchitis virus (Classic M41, GI-13 and GI-23 lineage strains) and LPAI subtype H9N2 |
|
24 |
MEVAC™ MULTI IB+H9+ND |
Pentavalent vaccine against Infectious Bronchitis virus (Classic M41, GI-13 and GI-23 lineage strains), LPAI subtype H9N2 and ND GII virus |
|
25 |
MEVAC™ EDS 76 |
Monovalent water-in-oil emulsion vaccine against Egg Drop Syndrome |
|
26 |
MEVAC™ ND+EDS |
Bivalent virus vaccine containing ND GII LaSota strain and Egg Drop Syndrome ’76 virus |
|
27 |
MEVAC™ ND+IB+EDS |
Pentavalent water-in-oil emulsion vaccine containing ND GII LaSota strain, IB virus (Classic M41, GI-13 and GI-23 lineage strains) and Egg Drop Syndrome ’76 virus |